Evidence map›Paper›PMID 20194630›Full record

ArticleThe Journal of experimental medicine2010

Essential roles of sphingosine-1-phosphate receptor 2 in human mast cell activation, anaphylaxis, and pulmonary edema.

Carole A Oskeritzian, Megan M Price, Nitai C Hait, Dmitri Kapitonov, Yves T Falanga, Johanna K Morales, John J Ryan, Sheldon Milstien, Sarah Spiegel

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of experimental medicine, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 71 papers.

0numbers the graph read from it
0cells of the map it votes in
71citing papers in PubMed
4.5field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

71 citing papers in PubMed, 111 citations in OpenAlex.

  1. Trial
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Suppressive Effect of CYM50358 S1PBiomolecules & therapeutics · 2021
    Article
  11. Article
  12. Article
  13. Topical Application of S1PBiomolecules & therapeutics · 2020
    Article
  14. Article
  15. Article
  16. Article
  17. Lipocalin 2: A New Antimicrobial in Mast Cells.International journal of molecular sciences · 2019
    Article
  18. Article
  19. Article
  20. Review

11 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Carole A OskeritzianDepartment of Biochemistry and Molecular Biology, Virginia Commonwealth University School of Medicine, Richmond, VA 23298, USA. coskerit@vcu.edu
Megan M Price
Nitai C Hait
Dmitri Kapitonov
Yves T Falanga
Johanna K Morales
John J Ryan
Sheldon Milstien
Sarah Spiegel
Virginia Commonwealth University · US

Funding

The Effect of Lyn Deficiency on Mast Cell Activation and Inflammatory Disease ProU19AI077435 · NIAID · VIRGINIA COMMONWEALTH UNIVERSITY · PI SCHWARTZ, LAWRENCE B. · 2008 to 2012
$7.7M
Targeting sphingosine kinases in FceRI-mediated allergic responsesR01AI050094 · NIAID · VIRGINIA COMMONWEALTH UNIVERSITY · PI SPIEGEL, SARAH · 2002 to 2012
$2.9M
Sphingosine-1-Phosphate, A Novel Mediator of Human Skin Mass Cell FunctionsK01AR053186 · NIAMS · VIRGINIA COMMONWEALTH UNIVERSITY · PI OSKERITZIAN, CAROLE A · 2006 to 2010
$522k
NIAID NIH HHS R01 AI050094NIAID NIH HHS R01AI50094NIAID NIH HHS U19 AI077435NIAID NIH HHS U19AI077435NIAMS NIH HHS K01 AR053186NIAMS NIH HHS K01AR053186
6 · The paper itself

Abstract

Systemic exacerbation of allergic responses, in which mast cells play a critical role, results in life-threatening anaphylactic shock. Sphingosine-1-phosphate (S1P), a ligand for a family of G protein-coupled receptors, is a new addition to the repertoire of bioactive lipids secreted by activated mast cells. Yet little is known of its role in human mast cell functions and in anaphylaxis. We show that S1P(2) receptors play a critical role in regulating human mast cell functions, including degranulation and cytokine and chemokine release. Immunoglobulin E-triggered anaphylactic responses, including elevation of circulating histamine and associated pulmonary edema in mice, were significantly attenuated by the S1P(2) antagonist JTE-013 and in S1P(2)-deficient mice, in contrast to anaphylaxis induced by administration of histamine or platelet-activating factor. Hence, S1P and S1P(2) on mast cells are determinants of systemic anaphylaxis and associated pulmonary edema and might be beneficial targets for anaphylaxis attenuation and prophylaxis.

Indexed as

AnaphylaxisAnimalsAntibodies, MonoclonalAntigensChemokinesCytokinesHumansHypersensitivityImmunoglobulin EMast CellsMiceMice, Inbred C57BLMice, KnockoutPulmonary EdemaReceptors, LysosphingolipidRodentiaAntibodies, MonoclonalAntigensChemokinesCytokinesImmunoglobulin EReceptors, LysosphingolipidS1PR2 protein, humanSphingosine-1-Phosphate Receptors

Identifiers

PMID20194630
PMCPMC2839150
OpenAlexW2119536609

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.